Position in ANIP
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$922,800
-$24,480 QoQ
Shares Held
12,000
0.0% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ANIP Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Jefferies Financial Group Inc. holds $32,795,534 across 16 Drug Manufacturers - Specialty & Generic names. ANIP ranks #7 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
507,909 | $15,481,066 | |
| 2 | PCRX |
Pacira BioSciences, Inc.
|
196,292 | $4,436,199 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
6,001 | $3,558,472 | |
| 4 | ZTS |
Zoetis Inc.
|
19,710 | $2,329,919 | |
| 5 | ANIK |
Anika Therapeutics, Inc.
|
93,500 | $1,355,750 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
31,564 | $950,707 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
This page
|
12,000 | $922,800 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
24,300 | $803,601 |
All Filings in ANIP
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $922,800 | 12,000 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $947,280 | 12,000 | Shares | Defined | 2026-02-09 | |
| No filing history on record for this holder in this stock. | ||||||